Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus eye drops versus fluorometholone eye drops for Sjogren's syndrome dry eye
ChiCTR-IPR-17013772Phase 4Not yet recruiting
- Sponsor
- Eye Hospital of Wenzhou Medical University
- Start
- Jan 2018
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tacrolimus and fluorometholone in dry eye syndrome (DED) and Sjögren's syndrome (2 arms), sponsored by Eye Hospital of Wenzhou Medical University. Primary endpoint: Eye dryness score. Planned start Jan 2018; status: not yet recruiting.
02
Drugs
tacrolimusfluorometholone
03
Conditions
dry eye syndrome (DED)Sjögren's syndrome
Beyond the preview
Go deeper on ChiCTR-IPR-17013772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17013772.